Cat Radioiodine and Renal Function Monitoring

Radioactive iodine treatment unmasks concurrent kidney disease in many hyperthyroid cats. Post-treatment monitoring prevents the transition from hyperthyroid to hypothyroid and uraemic.

Key Facts

Up to 40% of hyperthyroid cats develop overt kidney disease after becoming euthyroid
Hyperthyroidism increases renal blood flow masking underlying kidney dysfunction
T4, SDMA and creatinine should be measured 4-6 weeks after achieving euthyroidism
Hypothyroidism after treatment worsens renal function and must be treated
Some cats require reduced antithyroid therapy to balance thyroid and renal function

Welfare Considerations

The interplay between hyperthyroidism and kidney disease creates one of the most challenging welfare management situations in feline medicine. Cats that improve dramatically after I-131 treatment may deteriorate weeks later as kidney disease unmasked by euthyroidism becomes clinically significant. Monitoring renal function at 4-6 weeks and adjusting management accordingly is essential. Hypothyroidism reduces renal blood flow and must be identified and treated promptly. Some cats achieve the best welfare outcome with a slightly elevated T4 that maintains adequate renal perfusion while controlling hyperthyroidism symptoms.

What You Can Do

Schedule renal function testing at 4-6 weeks after radioactive iodine treatment
Monitor for signs of kidney disease: increased thirst, weight loss, reduced appetite
Request SDMA alongside creatinine for more sensitive early kidney disease detection
Report any return of lethargy or inappetence after initial post-treatment improvement
Work with your vet to balance thyroid and renal function through dose and target T4 adjustment